Extended Phenytoin Sodium

Product NDC
71610-479
11-digit product format
716100479
Labeler code
71610
Product ID
71610-479_444cd2c3-a0d4-4c73-b74e-284a212f288b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Phenytoin Sodium
Dosage form
CAPSULE
Route
ORAL
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Application
ANDA040765
Marketing category
ANDA
Marketing start
2020-08-25
Marketing end
0000-00-00
Substance
PHENYTOIN SODIUM
Active strength
100 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C8 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 2D6 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA]
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71610-479EXTENDED PHENYTOIN SODIUM (PHENYTOIN SODIUM) CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]1Legacy NDC20201113_f163208c-25e7-415b-ae17-9f5f5870e6e8.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
71610-479-607161004796090 CAPSULE in 1 BOTTLE (71610-479-60) 90 capsule2020-11-020000-00-00NoNoCurrent
71610-479-7071610047970120 CAPSULE in 1 BOTTLE (71610-479-70) 120 capsule2020-11-020000-00-00NoNoCurrent
71610-479-9271610047992270 CAPSULE in 1 BOTTLE (71610-479-92) 270 capsule2020-11-020000-00-00NoNoCurrent
71610-479-9471610047994360 CAPSULE in 1 BOTTLE (71610-479-94) 360 capsule2020-11-020000-00-00NoNoCurrent
71610-479-9871610047998540 CAPSULE in 1 BOTTLE (71610-479-98) 540 capsule2020-11-020000-00-00NoNoCurrent